Stock Track | DaVita HealthCare Partners Soars 5.15% Intraday Following Analyst Target Price Increases

Stock Track
02/04

DaVita HealthCare Partners (DVA) experienced a significant surge of 5.15% during intraday trading on Wednesday, reflecting strong positive investor sentiment.

The stock's upward movement appears to be driven by optimistic analyst commentary, including UBS raising its price target on DaVita to $190 from $186 and TD Cowen increasing its target to $144 from $133. These upward revisions suggest growing confidence among financial analysts regarding the company's future performance.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10